110: Celina Halioua

Celine is the founder and CEO of Loyal - a biotech startup developing drugs to extend dog lifespan. Before founding Loyal, Celine worked at the Longevity Fund - a venture capital fund investing in therapies with the potential to extend human lifespan. Celine studied the health economics of gene therapy while attending Oxford for her PhD. Prior to Oxford, she received her Bachelors in Neuroscience and Nanobiotechnology at the University of Texas at Austin and at Uppsala Universitet in Sweden.